Homepage
Medication Guide
How to Use Deflazacort (Calcort)
Deflazacort (Calcort) is a glucocorticoid drug with anti-inflammatory and immunosuppressive effects. Clinically, it is mainly used for the treatment of various inflammatory diseases and autoimmune dis...
509
Thursday, September 25th, 2025, 14:48
Indications for Deflazacort (Calcort)
Deflazacort (Calcort) is a glucocorticoid drug mainly used for the treatment of various inflammatory and autoimmune diseases.Indications for Deflazacort (Calcort)Duchenne Muscular Dystrophy (DMD)Defla...
511
Thursday, September 25th, 2025, 14:45
What Are the Side Effects of Eltrombopag (Revolade)?
Eltrombopag (Revolade) is a thrombopoietin receptor agonist used for the treatment of specific types of thrombocytopenia and aplastic anemia. Although it has good therapeutic efficacy, potential side ...
505
Thursday, September 25th, 2025, 14:38
How Effective is Eltrombopag (Revolade) in Treatment?
Eltrombopag (Revolade) is an oral thrombopoietin receptor agonist that plays an important role in the treatment of various hematological disorders.How Effective is Eltrombopag (Revolade) in Treatment?...
510
Thursday, September 25th, 2025, 14:32
Precautions for Eltrombopag (Revolade) Use
Eltrombopag (Revolade) is a thrombopoietin receptor agonist used for the treatment of chronic immune thrombocytopenia (ITP), chronic hepatitis C-related thrombocytopenia, and severe aplastic anemia. I...
508
Thursday, September 25th, 2025, 14:29
How to Use Eltrombopag (Revolade)
Eltrombopag (Revolade) is a thrombopoietin receptor agonist. Clinically, it is mainly used for the treatment of chronic immune thrombocytopenia (ITP), chronic hepatitis C-related thrombocytopenia, and...
511
Thursday, September 25th, 2025, 14:06
Indications for Eltrombopag (Revolade)
Eltrombopag (Revolade) is a thrombopoietin receptor agonist developed by GlaxoSmithKline, primarily indicated for the treatment of thrombocytopenia caused by various factors.Indications for Eltrombopa...
509
Wednesday, September 24th, 2025, 15:59
Precautions for Lorlatinib (Lorviqua) Administration
Lorlatinib (Lorviqua) is an inhibitor targeting anaplastic lymphoma kinase (ALK), primarily indicated for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC). As a highly effec...
507
Wednesday, September 24th, 2025, 15:56
How to Use Lorlatinib (Lorviqua)
Lorlatinib (Lorviqua) is an inhibitor targeting ALK and ROS1 kinases, indicated for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC).How to Use Lorlatinib (Lorviqua)Recommen...
507
Wednesday, September 24th, 2025, 15:52
Indications for Lorlatinib (Lorviqua)
Lorlatinib (Lorviqua) is an innovative kinase inhibitor targeting specific lung cancer biomarkers, approved for marketing by the U.S. FDA.Indications for Lorlatinib (Lorviqua)Primary IndicationsLorlat...
508
Wednesday, September 24th, 2025, 15:47
105 / 207
2069 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved